4//SEC Filing
Zarrabian Saiid 4
Accession 0001213900-18-006696
CIK 0001498382other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:25 AM ET
Size
5.5 KB
Accession
0001213900-18-006696
Insider Transaction Report
Form 4
Zarrabian Saiid
DirectorInterim CEO
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-21+836,465→ 836,465 totalExercise: $0.98Exp: 2028-05-21→ Common Stock (836,465 underlying)
Footnotes (1)
- [F1]1/6th of the options vest on November 21, 2018 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on December 21, 2018.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001495521
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 6:25 AM ET
- Size
- 5.5 KB